Microdosing Amanita muscaria means repeated small doses of fly agaric, a red-capped, white-spotted mushroom sold dried, as liquid, capsules, or gummies, for stress, sleep, and mood. No human trial with a comparison group has tested it for health or longevity; benefit signals are weak, indirect, and sometimes conflicting. Documented harms come from poison-center records and product testing; products are often mislabeled or contaminated. Safety at very small doses is unknown. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Liver enzymes (ALT, AST) | 10-26 U/L each | Baseline reserve; rules out liver injury from contaminants or misidentified mushrooms |
| Kidney function (creatinine, eGFR) | Creatinine 0.7-1.0 mg/dL; eGFR above 90 mL/min/1.73 m² | Both compounds are cleared by the kidneys |
| Blood lead | Below 2 µg/dL | Mushrooms accumulate lead |
| Blood cadmium | Below 0.5 µg/L | Mushrooms accumulate cadmium |
| Resting heart rate and blood pressure | 50-70 beats per minute; below 120/80 mmHg | Muscarine may slow heart rate; sedatives may lower blood pressure |
| Wearable-tracked sleep | No established target; change from own baseline in total sleep time and awakenings | Tests whether a claimed sleep benefit is real |
Cadence: Baseline first, including 2-4 weeks of sleep tracking; sleep and symptom scores weekly for the first month, heart rate and blood pressure at 1 and 4 weeks, liver and kidney panels at 3 months, then every 6-12 months, with metals repeated yearly or whenever the product or supplier changes